Europe Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028

Report Code : BMIRE00025755 | Region : Europe | Industry : Biotechnology | Published Date : 06/Sep/2022
Europe Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others)

The Europe human leukocyte antigen (HLA) testing market is expected to grow from US$ 188.49 million in 2022 to US$ 287.77 million by 2028; it is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

The broadening scope of applications of HLA testing makes it mandatory before several medical procedures. The histocompatibility laboratory at TriCore Reference Laboratories provides HLA-related testing for transplantation, platelet donation/blood transfusion, forensic testing, parentage testing, disease association, pharmacogenomics, and transfusion medicine applications; among these, HLA testing is commonly used in disease-association testing. Specific HLA alleles are associated with high or low exposure to various diseases. HLA testing can also be used as a complementary method for diagnosing and assessing hereditary risks. The confirmation of the presence or absence of HLA factors associated with each disease or drug-induced adverse reactions can significantly impact therapeutics. Further, blood transfusion is one of the primary procedures that require HLA testing. Several chronic conditions, surgical procedures, and trauma cases require blood transfusion so that patients can survive without any side effects of low blood levels. Conditions including thalassemia, blood cancer, sickle cell anemia, anemia, and surgical and trauma cases lead to blood loss and require a blood transfusion. Thus, the increasing prevalence of chronic diseases magnifies the demand for blood transfusion, thereby propelling the growth of the HLA testing market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.

Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Europe Human Leukocyte Antigen (HLA) Testing Market Segmentation

The Europe human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Europe human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the Europe human leukocyte antigen (HLA) testing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.

Europe Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned

THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina, Inc.; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; Takara Bio Inc.; Luminex Corporation; Omixon Inc.; Protrans; and CeGaT GmbH are among the major companies operating in the Europe human leukocyte antigen (HLA) testing market.

The List of Companies - Europe Human Leukocyte Antigen (HLA) Testing Market

● THERMO FISHER SCIENTIFIC INC.                            

● CareDx                                                                     

● QIAGEN                                                                                              

● Illumina, Inc.                                                                     

● Bio-Rad Laboratories, Inc.                                           

● F. HOFFMANN-LA ROCHE LTD.                                  

● Takara Bio Inc.                                                                  

● Luminex Corporation                                                    

● Omixon Inc.                                                                       

● Protrans                                                                              

● CeGaT GmbH

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Human Leukocyte Antigen (HLA) Testing Market – By Product and Services

1.3.2 Europe Human Leukocyte Antigen (HLA) Testing Market – By Technology

1.3.3 Europe Human Leukocyte Antigen (HLA) Testing Market – By End User

1.3.4 Europe Human Leukocyte Antigen (HLA) Testing Market – By Country

2. Europe Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Human Leukocyte Antigen (HLA) Testing Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe – PEST Analysis

4.3 Expert Opinion

5. Europe Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures

5.1.2 Expanding Range of Applications of HLA Testing

5.2 Market Restraints

5.2.1 Errors in Accuracy

5.3 Market Opportunities

5.3.1 Rising Government Funding for Organ Donation

5.4 Future Trends

5.4.1 Technological Advancements in Field of Histocompatibility

5.5 Impact Analysis

6. Europe Human Leukocyte Antigen (HLA) Testing Market –Analysis

6.1 Europe Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

7. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services

7.1 Overview

7.2 Europe Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

7.3 Reagents and Consumables

7.3.1 Overview

7.3.2 Reagents and Consumables: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services : Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

8. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology

8.1 Overview

8.2 Europe Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

8.3 Molecular Assay Technologies

8.3.1 Overview

8.3.2 Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.3 PCR-Based Molecular Assays

8.3.3.1 Overview

8.3.3.2 PCR-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.4 Sequencing-Based Molecular Assays

8.3.4.1 Overview

8.3.4.2 Sequencing-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.5 Others

8.3.5.1 Overview

8.3.5.2 Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Non-Molecular Assay Technologies

8.4.1 Overview

8.4.2 Non-Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User

9.1 Overview

9.2 Europe Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)

9.3 Independent Reference Laboratories

9.3.1 Overview

9.3.2 Independent Reference Laboratories: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.4 Hospital & Transplant Centers

9.4.1 Overview

9.4.2 Hospital & Transplant Centers: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Country

10.1 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market

10.1.1 Overview

10.1.2 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)

10.1.3 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.4 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.4.1 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.5 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6 Europe: Europe Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.1.6.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.1.3 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.3.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.4 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.2 France: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 France: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2 France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.2.3 France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.3.1 France: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.4 France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.3 UK: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 UK: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.3.3 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.3.1 UK: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.4 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.4 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.2 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.4.3 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.4.3.1 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.4.4 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.5 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.1 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.2 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.5.3 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.5.3.1 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.5.4 Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.6 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.1 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.2 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.6.3 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.6.3.1 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.6.4 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

11. Europe Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Europe Human Leukocyte Antigen (HLA) Testing Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 THERMO FISHER SCIENTIFIC INC.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 CareDx

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QIAGEN

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Illumina, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Bio-Rad Laboratories, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 F. HOFFMANN-LA ROCHE LTD.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Takara Bio Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Luminex Corporation

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Omixon Inc.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Protrans

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 CeGaT GmbH

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 2. Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 3. Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 4. Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 5. Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 6. Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 7. Germany: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 8. Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 9. France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 10. France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 11. France: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 12. France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 13. UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 14. UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 15. UK: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 16. UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 17. Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 18. Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 19. Italy: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 20. Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 21. Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 22. Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 23. Spain: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 24. Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 25. Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 26. Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 27. Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 28. Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 29. Organic Developments in the Europe Human Leukocyte Antigen (HLA) Testing Market

Table 30. Inorganic Developments in the Europe Human Leukocyte Antigen (HLA) Testing Market

Table 31. Glossary of Terms, Europe Human Leukocyte Antigen (HLA) Testing Market

The List of Companies - Europe Human Leukocyte Antigen (HLA) Testing Market

● THERMO FISHER SCIENTIFIC INC.                            

● CareDx                                                                     

● QIAGEN                                                                                              

● Illumina, Inc.                                                                     

● Bio-Rad Laboratories, Inc.                                           

● F. HOFFMANN-LA ROCHE LTD.                                  

● Takara Bio Inc.                                                                  

● Luminex Corporation                                                    

● Omixon Inc.                                                                       

● Protrans                                                                              

● CeGaT GmbH

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Human Leukocyte Antigen (HLA) Testing Market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in Europe Human Leukocyte Antigen (HLA) Testing Market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Europe Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry